184 related articles for article (PubMed ID: 34560169)
21. Opinion of the Scientific Committee on consumer safety (SCCS) - Opinion on the use of 2,2'-methylene-bis-(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol) (nano) - S79 - In cosmetic products.
; Doak SH
Regul Toxicol Pharmacol; 2016 Apr; 76():215-6. PubMed ID: 26776753
[No Abstract] [Full Text] [Related]
22. Opinion of the Scientific Committee on Consumer safety (SCCS) - Revision of the opinion on the safety of the use of titanium dioxide, nano form, in cosmetic products.
; Chaudhry Q
Regul Toxicol Pharmacol; 2015 Nov; 73(2):669-70. PubMed ID: 26363206
[No Abstract] [Full Text] [Related]
23. Opinion of the scientific committee on consumer safety (SCCS) - Final opinion on Polyaminopropyl Biguanide (PHMB) in cosmetic products - Submission III.
; Rogiers V;
Regul Toxicol Pharmacol; 2017 Aug; 88():328-329. PubMed ID: 28483711
[No Abstract] [Full Text] [Related]
24. Opinion of the Scientific Committee on Consumer safety (SCCS) - Final opinion on water-soluble zinc salts used in oral hygiene products.
; Granum B
Regul Toxicol Pharmacol; 2018 Nov; 99():249-250. PubMed ID: 30267827
[TBL] [Abstract][Full Text] [Related]
25. Opinion of the Scientific Committee on Consumer Safety (SCCS) - Final version of the Opinion on Vitamin A (retinol, retinyl acetate and retinyl palmitate) in cosmetic products.
; Rousselle C
Regul Toxicol Pharmacol; 2017 Mar; 84():102-104. PubMed ID: 27856323
[No Abstract] [Full Text] [Related]
26. Opinion of the Scientific Committee on Consumer safety (SCCS) - Opinion on the safety of cosmetic ingredient salicylic acid (CAS 69-72-7).
Sccs ; Panteri E; ;
Regul Toxicol Pharmacol; 2019 Nov; 108():104376. PubMed ID: 31401081
[No Abstract] [Full Text] [Related]
27. SCCS scientific opinion on Butylated hydroxytoluene (BHT) - SCCS/1636/21.
; Granum Rapporteur B; Bernauer U; Bodin L; Chaudhry Q; Pieter Jan C; Dusinska M; Ezendam J; Gaffet E; Galli CL; Panteri E; Rogiers V; Rousselle C; Stepnik M; Vanhaecke T; Wijnhoven S; ; Koutsodimou A; Uter W; von Goetz N
Regul Toxicol Pharmacol; 2023 Feb; 138():105312. PubMed ID: 36565917
[TBL] [Abstract][Full Text] [Related]
28. Opinion of the Scientific Committee on Consumer safety (SCCS) - Opinion on Ethylzingerone - 'Hydroxyethoxyphenyl Butanone' (HEPB) - Cosmetics Europe No P98 - CAS No 569646-79-3 - Submission II (eye irritation).
;
Regul Toxicol Pharmacol; 2019 Oct; 107():104393. PubMed ID: 31170420
[TBL] [Abstract][Full Text] [Related]
29. Gold Nanomaterials in Consumer Cosmetics Nanoproducts: Analyses, Characterization, and Dermal Safety Assessment.
Cao M; Li J; Tang J; Chen C; Zhao Y
Small; 2016 Oct; 12(39):5488-5496. PubMed ID: 27562146
[TBL] [Abstract][Full Text] [Related]
30. SCCS Scientific Opinion on Acid Yellow 3 (submission II) - SCCS/1631/21.
; Galli Rapporteur CL; Bernauer U; Bodin L; Chaudhry Q; Coenraads PJ; Dusinska M; Ezendam J; Granum B; Gaffet E; Panteri E; Rogiers V; Rousselle C; Stepnik M; Vanhaecke T; Wijnhoven S; ; Koutsodimou A; Uter W; von Goetz N
Regul Toxicol Pharmacol; 2023 May; 140():105364. PubMed ID: 36907371
[TBL] [Abstract][Full Text] [Related]
31. Nanotechnology in cosmetics.
Katz LM; Dewan K; Bronaugh RL
Food Chem Toxicol; 2015 Nov; 85():127-37. PubMed ID: 26159063
[TBL] [Abstract][Full Text] [Related]
32. New Zealand's regulation of cosmetic products containing nanomaterials.
Moore J
J Bioeth Inq; 2012 Jun; 9(2):185-8. PubMed ID: 23180261
[TBL] [Abstract][Full Text] [Related]
33. Opinion of the Scientific Committee on Consumer Safety (SCCS)--The safety of the use of formaldehyde in nail hardeners.
; Bernauer U; Coenraads PJ; Degen GH; Dusinska M; Lilienblum W; Luch A; Nielsen E; Platzek T; Rastogi S; Rousselle C; van Benthem J; Bernard A; Giménez-Arnau AM; Vanhaecke T
Regul Toxicol Pharmacol; 2015 Aug; 72(3):658-9. PubMed ID: 25819931
[No Abstract] [Full Text] [Related]
34. Opinion of the Scientific Committee on Consumer safety (SCCS) - Opinion on the safety of the use of deoxyarbutin in cosmetic products.
Sccs ; Degen GH
Regul Toxicol Pharmacol; 2016 Feb; 74():77-8. PubMed ID: 26646660
[TBL] [Abstract][Full Text] [Related]
35. Is the European regulatory framework sufficient to assure the safety of citizens using health products containing nanomaterials?
Musazzi UM; Marini V; Casiraghi A; Minghetti P
Drug Discov Today; 2017 Jun; 22(6):870-882. PubMed ID: 28189800
[TBL] [Abstract][Full Text] [Related]
36. Consumers' lack of understanding of customized cosmetics made on the spot and implications for regulations and controls.
Kim HW; Seok YS; Lee HG; Song MK; Rhee MS
Regul Toxicol Pharmacol; 2021 Aug; 124():104979. PubMed ID: 34197870
[TBL] [Abstract][Full Text] [Related]
37. [Nanomaterials in cosmetics--present situation and future].
Masunaga T
Yakugaku Zasshi; 2014; 134(1):39-43. PubMed ID: 24389615
[TBL] [Abstract][Full Text] [Related]
38. Changes in European legislation make it timely to introduce a transparent market surveillance system for cosmetics.
Lodén M; Ungerth L; Serup J
Acta Derm Venereol; 2007; 87(6):485-92. PubMed ID: 17989885
[TBL] [Abstract][Full Text] [Related]
39. Consumer protection provided by the European medical device and cosmetic legislation for condoms and lubricants.
Desmedt B; Vanhamme M; Vanhee C; Rogiers V; Deconinck E
Regul Toxicol Pharmacol; 2019 Apr; 103():106-112. PubMed ID: 30659873
[TBL] [Abstract][Full Text] [Related]
40. Probabilistic exposure assessment to face and oral care cosmetic products by the French population.
Bernard A; Dornic N; Roudot A; Ficheux A
Food Chem Toxicol; 2018 Jan; 111():511-524. PubMed ID: 29198857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
